RFC
AVEO

Russell Frank Company’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Russell Frank Company’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,741
Closed -$87K – 3081
2015
Q4 		$87K Buy
+6,741
New +$80.1K ﹤0.01% 2824
2015
Q2 		– Sell
-6,425
Closed -$93K – 3117
2015
Q1 		$93K Buy
+6,425
New +$70.2K ﹤0.01% 2748
2013
Q4 		– Sell
-5,342
Closed -$111K – 3185
2013
Q3 		$111K Buy
5,342
+5,317
+21,268% +$122K ﹤0.01% 2929
2013
Q2 		$1K Buy
+25
New +$1.07K ﹤0.01% 3284

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Russell Frank Company's AVEO Position: Q1 2016 in Review

Russell Frank Company sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2016, closing a stake of 6,741 shares — an estimated $87K sold.

Russell Frank Company first reported a position in AVEO in Q2 2013 and held it in 4 quarters. The position peaked at $111K in Q3 2013. 41 funds tracked by Wall St. Rank hold AVEO as of Q1 2016.

  • Russell Frank Company reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Russell Frank Company sold 6,741 AVEO Pharmaceuticals, Inc. shares in Q1 2016, an estimated $87K.
  • Russell Frank Company first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
  • Russell Frank Company's AVEO Pharmaceuticals, Inc. position peaked at $111K in Q3 2013.
  • 41 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.